CD4 and hepatocellular carcinoma: In HCC, circulating and tumor-infiltrating CD4+ cytotoxic T cells are increased in early stages of HCC but are decreased in advanced stages; loss of CD4+ cytotoxic T cells is significantly correlated with high mortality rate and reduces survival time of HCC patients [12].